BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Development of biofluid-based molecular diagnostic tests for cancer is an important step towards tumor characterization and real-time monitoring in a minimally invasive fashion. Extracellular vesicles (EVs) are released from tumor cells into body fluids and can provide a powerful platform for tumor...
Saved in:
Main Authors: | Walter W Chen (Author), Leonora Balaj (Author), Linda M Liau (Author), Michael L Samuels (Author), Steve K Kotsopoulos (Author), Casey A Maguire (Author), Lori LoGuidice (Author), Horacio Soto (Author), Matthew Garrett (Author), Lin Dan Zhu (Author), Sarada Sivaraman (Author), Clark Chen (Author), Eric T Wong (Author), Bob S Carter (Author), Fred H Hochberg (Author), Xandra O Breakefield (Author), Johan Skog (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent advances of IDH1 mutant inhibitor in cancer therapy
by: Wangqi Tian, et al.
Published: (2022) -
A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted
by: Vani Santosh, et al.
Published: (2022) -
Population pharmacokinetic and exposure‐response analyses of ivosidenib in patients with IDH1‐mutant advanced hematologic malignancies
by: Xuemin Jiang, et al.
Published: (2021) -
Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases
by: Jiangfen Zhou, et al.
Published: (2022) -
Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
by: Binghao Zhao, et al.
Published: (2022)